Bravecto Transdermal for cats weighing 2.8 to 6.25 kg is a topical flea and tick repellent administered by pipette in a 0.89 mL dose containing 250 mg of fluralaner. It offers protection against parasites for up to 12 weeks ### Indications and use - Indicated for cats weighing between 2.8 and 6.25 kg - Single topical application every 8 to 12 weeks - Should not be used in cats under 11 weeks of age or weighing less than 1.2 kg - Contraindicated in cases of hypersensitivity to the components - Safety not established in pregnant or lactating cats ### Side effects - Rare cases (1.6% to 2.9%) of mild and transient reactions, such as redness, itching, hair loss and scaling at the application site - Mild and transient gastrointestinal reactions such as diarrhea, vomiting, loss of appetite and salivation were observed in approximately 1.6% of cats - Symptoms such as apathy, tremors and anorexia occurred in 0.9% of cases; vomiting and hypersalivation in 0.4% - In very rare cases (0.1%) dyspnea, hematemesis, lethargy, fever, tachypnea and mydriasis were reported after administration ### Considerations - The product is for veterinary use and should be applied according to professional guidance - A minimum interval of 8 weeks between applications must be respected - The choice of Bravecto Transdermal should consider the cat's weight and health conditions to ensure safety and efficacy In summary, Bravecto Transdermal for cats from 2.8 to 6.25 kg is an effective topical solution for flea and tick control, with rare and generally mild side effects, being a practical option for the prolonged protection of your cat.
